---
document_datetime: 2023-09-21 20:11:35
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/briviact-epar-all-authorised-presentations_en.pdf
document_name: briviact-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.1958889
conversion_datetime: 2025-12-24 01:17:18.833703
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                     | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------------------------|----------------------------------|
| EU/1/15/1073/001 | Briviact          | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 14 tablets                       |
| EU/1/15/1073/002 | Briviact          | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 56 tablets                       |
| EU/1/15/1073/003 | Briviact          | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 100 x 1 tablets (unit dose)      |
| EU/1/15/1073/004 | Briviact          | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 168 (3 x 56) tablets (multipack) |
|                  | Briviact          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 14 tablets                       |
| EU/1/15/1073/006 | Briviact          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 56 tablets                       |
| EU/1/15/1073/007 | Briviact          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 100 x 1 tablets (unit dose)      |
| EU/1/15/1073/008 | Briviact          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 168 (3 x 56) tablets (multipack) |
| EU/1/15/1073/009 | Briviact          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 14 tablets                       |
| EU/1/15/1073/010 | Briviact          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 56 tablets                       |
| EU/1/15/1073/011 | Briviact          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 100 x 1 tablets (unit dose)      |
| EU/1/15/1073/012 | Briviact          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 168 (3 x 56) tablets (multipack) |
| EU/1/15/1073/013 | Briviact          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 14 tablets                       |
| EU/1/15/1073/014 | Briviact          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 56 tablets                       |
| EU/1/15/1073/015 | Briviact          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 100 x 1 tablets (unit dose)      |
| EU/1/15/1073/016 | Briviact          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 168 (3 x 56) tablets (multipack) |
| EU/1/15/1073/017 | Briviact          | 100 mg     | Film-coated tablet    | Oral use                  | blister                                 | 14 tablets                       |
| EU/1/15/1073/018 | Briviact          | 100 mg     | Film-coated tablet    | Oral use                  | (PVC/PCTFE/alu) blister (PVC/PCTFE/alu) | 56 tablets                       |
| EU/1/15/1073/019 | Briviact          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 100 x 1 tablets (unit dose)      |
| EU/1/15/1073/020 | Briviact          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu)                 | 168 (3 x 56) tablets (multipack) |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form             | Route of Administration   | Immediate Packaging     | Content (concentration)   | Pack size                                                                      |
|------------------|-------------------|------------|---------------------------------|---------------------------|-------------------------|---------------------------|--------------------------------------------------------------------------------|
| EU/1/15/1073/021 | Briviact          | 10 mg/ml   | Oral solution                   | Oral use                  | bottle (glass)          | 300 ml                    | 1 bottle + 1 oral syringe of 5 ml + 1 oral syringe of 10 ml + 1 bottle adaptor |
| EU/1/15/1073/022 | Briviact          | 10 mg/ml   | Solution for injection/infusion | Intravenous use           | vial (glass)            | 5 ml                      | 10 vials                                                                       |
| EU/1/15/1073/023 | Briviact          | 10 mg      | Film-coated tablet              | Oral use                  | blister (PVC/PCTFE/alu) |                           | 14 x 1 tablets (unit dose)                                                     |
| EU/1/15/1073/024 | Briviact          | 25 mg      | Film-coated tablet              | Oral use                  | blister (PVC/PCTFE/alu) |                           | 14 x 1 tablets (unit dose)                                                     |
| EU/1/15/1073/025 | Briviact          | 50 mg      | Film-coated tablet              | Oral use                  | blister (PVC/PCTFE/alu) |                           | 14 x 1 tablets (unit dose)                                                     |
| EU/1/15/1073/026 | Briviact          | 75 mg      | Film-coated tablet              | Oral use                  | blister (PVC/PCTFE/alu) |                           | 14 x 1 tablets (unit dose)                                                     |
| EU/1/15/1073/027 | Briviact          | 100 mg     | Film-coated tablet              | Oral use                  | blister (PVC/PCTFE/alu) |                           | 14 x 1 tablets (unit dose)                                                     |